NEW YORK--(BUSINESS WIRE)--Pluristem Therapeutics Inc. (NasdaqCM:PSTI) (DAX:PJT), a bio-therapeutics company dedicated to the commercialization of unrelated donor-patient (allogeneic) cell therapy products for a variety of disorders, announced today that Mr. Zami Aberman, its President and CEO, and Mr. Yaky Yanay, its VP Finance and CFO, have been invited to be featured speakers at the Center for Finance Education Conference in Ramat Efal, Israel, to be held on May 24, 2009. Their presentation, titled "The Human Placenta as a Source for Cell Therapy, Transforming the Vision into Reality", will take place at the Beit-Homa Hall.
